Stocks · Health care · Services-Medical Laboratories

BIODESIX INC

BDSX Clue Score48
United States Fiscal year ends December CIK 0001439725 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Scott Hutton
23 Feb 2026
President & CEO
Sell
1,490
$12.78
$19.04K
Chris Vazquez
23 Feb 2026
Chief Accounting Officer
Sell
211
$12.78
$2.70K
Robin Harper Cowie
23 Feb 2026
CFO, Sec'y & Treasurer
Sell
535
$12.78
$6.83K
Kieran O'Kane
23 Feb 2026
Chief Commercial Officer
Sell
535
$12.78
$6.83K
Gary Anthony Pestano
23 Feb 2026
Chief Development Officer
Sell
556
$12.78
$7.10K
Gary Anthony Pestano
10 Feb 2026
Chief Development Officer
Sell
540
$10.08
$5.45K
Robin Harper Cowie
10 Feb 2026
CFO, Sec'y & Treasurer
Sell
941
$10.08
$9.49K
Scott Hutton
10 Feb 2026
President & CEO
Sell
3,559
$10.08
$35.89K
Chris Vazquez
10 Feb 2026
Chief Accounting Officer
Sell
101
$10.08
$1.02K
Kieran O'Kane
10 Feb 2026
Chief Commercial Officer
Sell
584
$10.08
$5.89K
Robin Harper Cowie
16 Jan 2026
CFO, Sec'y & Treasurer
Sell
298
$8.15
$2.43K
Scott Hutton
16 Jan 2026
President & CEO
Sell
970
$8.15
$7.90K
Kieran O'Kane
16 Jan 2026
Chief Commercial Officer
Sell
298
$8.15
$2.43K
Gary Anthony Pestano
16 Jan 2026
Chief Development Officer
Sell
298
$8.15
$2.43K
Chris Vazquez
16 Jan 2026
Chief Accounting Officer
Sell
83
$8.15
$676.39

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 37,235
History held since 3 Nov 2020